Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer

N-803-BCG combination shows promising results in BCG-unresponsive NMIBC

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

ASCO and WHO to collaborate on quality indicators for cancer facilities

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer

Cancer Services Delivery: Focus on India

Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre

The role of the Global Coalition for Radiotherapy in the war in Ukraine